Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 4067597, 12 pages
Review Article

Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder

Laboratory of Neurosciences, Hospital Infantil de México Federico Gómez, Mexico

Correspondence should be addressed to Juan Carlos Corona; xm.ude.gfmih@anorocj

Received 28 June 2018; Revised 31 October 2018; Accepted 11 November 2018; Published 22 November 2018

Guest Editor: Francesco Facchiano

Copyright © 2018 Juan Carlos Corona. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Juan Carlos Corona, Sonia Carreón-Trujillo, Raquel González-Pérez, Denise Gómez-Bautista, Daniela Vázquez-González, and Marcela Salazar-García, “Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Chunhui Huang, Zaijun Zhang, and Wei Cui, “Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease,” Marine Drugs, vol. 17, no. 4, pp. 221, 2019. View at Publisher · View at Google Scholar
  • Salman Ahmed, Haroon Khan, Michael Aschner, Muhammad Mohtasheemul Hasan, and Sherif T.S. Hassan, “Therapeutic potential of naringin in neurological disorders,” Food and Chemical Toxicology, vol. 132, pp. 110646, 2019. View at Publisher · View at Google Scholar